Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Amgen (AMGN) Stock Declines While Market Improves: Some Information for Investors
07:06pm, Monday, 23'rd Sep 2024
In the closing of the recent trading day, Amgen (AMGN) stood at $335.61, denoting a -0.52% change from the preceding trading day.
AMGEN TO HOST CONFERENCE CALL TO DISCUSS NEW TOPLINE DATA IN INFLAMMATION AND RARE DISEASE
04:00pm, Monday, 23'rd Sep 2024
THOUSAND OAKS, Calif. , Sept. 23, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcasted call for the investment community at 1:30 p.m.
Amgen vs. Viking Therapeutics: What's the Better GLP-1 Stock to Buy?
07:30am, Monday, 23'rd Sep 2024
Many healthcare companies are working hard now on developing the next big weight loss drug. Industry veteran Amgen has an exciting treatment that may not require frequent injections.
Raise Cash And Sell Trash
08:05am, Saturday, 21'st Sep 2024
As a dividend growth investor focused on income, I recommend raising cash and selling lower-quality stocks due to potential recession risks. Historical data shows that rate cuts often precede recessio
Where Will Amgen Be in 5 Years?
07:45am, Friday, 20'th Sep 2024
Amgen's recent acquisition grants it a significant opportunity. The biotech is developing important medicines of its own.
Jim Cramer reviews 10 stocks that perform well just after the start of a cutting cycle
06:56pm, Thursday, 19'th Sep 2024
CNBC's Jim Cramer on Thursday reviewed stocks that have historically performed well just after the Federal Reserve embarks on a cutting cycle and chose his favorites. Using data compiled by CNBC Pro,
Amgen (AMGN) Stock Dips While Market Gains: Key Facts
06:56pm, Tuesday, 17'th Sep 2024
Amgen (AMGN) reachead $332.80 at the closing of the latest trading day, reflecting a -0.73% change compared to its last close.
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
10:00am, Tuesday, 17'th Sep 2024
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Amgen (AMGN) Rises Higher Than Market: Key Facts
07:05pm, Monday, 16'th Sep 2024
Amgen (AMGN) closed the most recent trading day at $335.26, moving +0.85% from the previous trading session.
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $500
10:00am, Friday, 13'th Sep 2024
Healthcare and travel are both durable targets for consumer spending over the long term. Amgen delivered excellent financial figures in the recent quarter, driven by new and flagship products.
AMGEN TO PRESENT DATA FROM MULTIPLE EARLY-STAGE CLINICAL TRIALS AT ESMO 2024
09:00am, Friday, 13'th Sep 2024
Results Illustrate Depth and Diversity of Amgen's Targeted Therapies Across Tumor Types THOUSAND OAKS, Calif. , Sept. 13, 2024 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the presentation o
Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now
06:00am, Thursday, 12'th Sep 2024
Eli Lilly and Novo Nordisk have been top stocks for investors who are bullish on the weight loss market. However, fellow biotech Amgen could possess more upside given its more modest valuation.
Why Amgen (AMGN) Outpaced the Stock Market Today
06:55pm, Tuesday, 10'th Sep 2024
Amgen (AMGN) reachead $328.93 at the closing of the latest trading day, reflecting a +0.92% change compared to its last close.
Tango Therapeutics: Amgen Missteps Devalue PRMT5 Candidates Ahead Of Critical Data
12:45pm, Tuesday, 10'th Sep 2024
Tango Therapeutics, Inc. offers high-risk, high-reward exposure to PRMT5-inhibitor drugs, with two candidates, TNG908 and TNG462, targeting MTAP-deleted cancers, a substantial market opportunity. TNGX
AMGEN PRESENTS NEW DATA FOR FIRST-IN-CLASS IMDELLTRA™ (TARLATAMAB-DLLE) IN SMALL CELL LUNG CANCER AT WCLC 2024
09:00am, Monday, 09'th Sep 2024
DeLLphi-303 Study Results Show Potential for IMDELLTRA in Combination with a PD-L1 Inhibitor as First-Line Maintenance Therapy in ES-SCLC DeLLphi-301 Long-Term Follow-up Data Demonstrate Sustained Saf
